Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Other Operating Expenses (2013 - 2023)

Scynexis' (SCYX) quarterly Other Operating Expenses came in at $14.7 million in Q4 2023, up 7391.84% on a YoY basis from $196000.0 in Q4 2022, and up 3774.41% quarter-over-quarter from $379000.0 in Q3 2023.

Analysis

Scynexis (SCYX) Other Operating Expenses (2013 - 2023) Analysis & Trends

Scynexis (SCYX) has reported Other Operating Expenses for 6 consecutive years, with $14.7 million the latest figure, recorded in Q4 2023.

  • For the quarter ending Q4 2023, Other Operating Expenses rose 7391.84% year-over-year to $14.7 million; the trailing twelve-month figure through Sep 2024 stood at $14.7 million (up 1190.33% YoY), and the FY2023 full-year result was $15.6 million, up 2387.9% from the prior year.
  • Other Operating Expenses rose to $14.7 million in Q4 2023 per SCYX's latest filing, from $379000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $14.7 million in Q4 2023 and bottomed at $99000.0 in Q1 2022.
  • Historically, Other Operating Expenses has averaged $1.7 million across 3 years, with a median of $178000.0 in 2021.
  • The sharpest annual moves came in 2022 and 2023: Other Operating Expenses climbed 17.37% in 2022, then soared 7391.84% in 2023.
  • Over 3 years, Other Operating Expenses stood at $167000.0 in 2021, then increased by 17.37% to $196000.0 in 2022, then jumped by 7391.84% to $14.7 million in 2023.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered $14.7 million, $379000.0, and $426000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 14.68 Mn
Sep 30, 2023 379,000.00
Jun 30, 2023 426,000.00
Mar 31, 2023 137,000.00
Dec 31, 2022 196,000.00
Sep 30, 2022 189,000.00
Jun 30, 2022 144,000.00
Mar 31, 2022 99,000.00
Dec 31, 2021 167,000.00
Sep 30, 2021 145,000.00
Mar 31, 2017 -19,000.00
Dec 31, 2016 -42,000.00
Sep 30, 2016 -201,000.00
Sep 30, 2013 2,000.00
Jun 30, 2013 472,000.00
Mar 31, 2013 514,000.00